Keywords: strong, ph, i/ii, data, cell, thera, pixantrone

Strong Ph I/II data for Cell Thera's pixantrone

Article | 27 March 2006

Print This

USA-based Cell Therapeutics has reported strong preliminary results from a Phase I/II trial of its cancer drug candidate pixantrone ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in